LakeShore Biopharma Co Gross Profit

As of the most recent data (March 2024), YS shows a gross profit of $390M. That is below the sector sector average of $790M. Scroll down for historical charts and peer comparison views.

The its sector sector average gross profit is about $790M. LakeShore Biopharma Co is at $390M, which is lower that average. That is roughly 51.2% below the sector mean. Use the comparison chart on this page to see how YS stacks up against individual peers as well.

Tracking YS's gross profit over time shows whether LakeShore Biopharma Co is scaling, shrinking, or reshaping that part of the business. The current reading is $390M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this gross profit page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect gross profit (currently $390M) with ownership activity and broader fundamentals.